Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset - HMS LINCS Database

Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Download: Excel (XLSX), Comma-separated (CSV)

Filter results: >>>>

|<
<<
Previous
Page 12 of 18
Next
>>
>
276 to 300 of 432 records
per page:

Cell line	Drug name	Experimental replicate	Timepoint	Curve type (GR values)	Curve type (relative cell counts)	Experiment name	Number of concentrations	Cell doublings (DMSO control)	GR50	GRmax	GR_AOC	GEC50	GRinf	Hill slope (GR values)	R-squared sigmoid fit (GR values)	P-value sigmoid fit (GR values)	R-squared flat fit (GR values)	IC50	Emax	AUC	EC50	Einf	Hill slope (relative cell counts)	R-squared sigmoid fit (relative cell counts)	P-value sigmoid fit (relative cell counts)	R-squared flat fit (relative cell counts)
HCC70	PI103	3	72	sigmoid	sigmoid	HCC70 PI-103 0 3 72	8	2.446	1.51	0.227	0.0983	1.57	-0.0288	1.54	0.986	2.66e-06	NA	1.48	0.303	0.906	1.15	0.168	1.59	0.976	1.42e-05	NA
HCC70	AS605240	3	72	sigmoid	sigmoid	HCC70 AS-605240 0 3 72	8	2.447	Inf	0.58	0.112	0.427	0.549	1.18	0.985	3.24e-06	NA	Inf	0.562	0.877	0.345	0.544	1.24	0.982	6.14e-06	NA
BT-20	MK2206	3	72	sigmoid	sigmoid	BT20 MK-2206 0 3 72	8	2.449	1.73	0.252	0.12	3.23	-0.504	1.11	0.988	1.77e-06	NA	1.69	0.318	0.877	1.69	0.0	1.18	0.979	9.03e-06	NA
HCC70	Pictilisib	3	72	sigmoid	sigmoid	HCC70 pictilisib 0 3 72	8	2.450	1.32	0.305	0.102	0.938	0.225	1.76	0.983	4.73e-06	NA	1.28	0.351	0.901	0.766	0.303	1.81	0.973	2.06e-05	NA
HCC70	Omipalisib	3	72	sigmoid	sigmoid	HCC70 omipalisib 0 3 72	8	2.458	0.0158	-0.404	0.771	0.0319	-0.379	0.8	0.99	8.95e-07	NA	0.0148	0.051	0.376	0.0127	0.0733	1.02	0.996	4.59e-08	NA
BT-20	Torin2	3	72	sigmoid	sigmoid	BT20 Torin2 0 3 72	8	2.458	0.019	-0.64	0.751	0.234	-1.0	0.438	0.959	6.92e-05	NA	0.0147	0.0148	0.379	0.0123	0.0598	0.727	0.977	1.28e-05	NA
HCC70	TGX221	3	72	sigmoid	sigmoid	HCC70 TGX-221 0 3 72	8	2.459	Inf	0.7	0.0886	0.338	0.675	1.11	0.971	2.48e-05	NA	Inf	0.671	0.9	0.295	0.648	1.13	0.966	3.94e-05	NA
Hs 578T	TGX221	2		sigmoid	sigmoid	Hs578T TGX-221 2	8	2.462	Inf	0.816	0.0307	0.904	0.781	1.29	0.964	4.56e-05	NA	Inf	0.789	0.964	0.834	0.754	1.3	0.96	6.63e-05	NA
HCC70	Trametinib	3	72	sigmoid	sigmoid	HCC70 trametinib 0 3 72	8	2.463	Inf	0.56	0.361	0.00419	0.548	0.954	0.95	0.000123	NA	Inf	0.542	0.618	0.00342	0.533	0.965	0.958	7.33e-05	NA
HCC70	Alpelisib	3	72	flat	flat	HCC70 alpelisib 0 3 72	8	2.465	Inf	0.859	0.027	0.0	0.859	0.01	0.407	0.209	0.961	Inf	0.835	0.968	0.0	0.835	0.01	0.394	0.222	0.954
HCC70	BX-912	3	72	sigmoid	sigmoid	HCC70 BX-912 0 3 72	8	2.465	1.26	0.174	0.0739	1.16	0.168	5.0	0.988	1.75e-06	NA	1.26	0.269	0.935	1.08	0.265	5.0	0.977	1.15e-05	NA
Hs 578T	PIK-93	2		sigmoid	sigmoid	Hs578T PIK-93 2	8	2.467	2.43	0.415	0.0931	3.62	-0.243	0.991	0.991	8.05e-07	NA	2.34	0.426	0.901	1.93	0.0909	1.04	0.987	2.24e-06	NA
BT-20	TGX221	3	72	flat	flat	BT20 TGX-221 0 3 72	8	2.469	Inf	1.01	0.0147	0.0	1.01	0.01	-0.0563	1.0	0.982	Inf	1.01	0.983	0.0	1.01	0.01	-0.0552	1.0	0.979
HCC70	KIN001-244	3	72	flat	flat	HCC70 KIN001-244 0 3 72	8	2.472	Inf	0.916	0.0295	0.0	0.916	0.01	-0.0208	1.0	0.969	Inf	0.899	0.965	0.0	0.899	0.01	-0.00883	1.0	0.963
HCC70	XL147	3	72	flat	flat	HCC70 pilaralisib 0 3 72	8	2.478	Inf	1.03	-0.0199	0.0	1.03	0.01	-0.318	1.0	1.02	Inf	1.03	1.03	0.0	1.03	0.01	-0.331	1.0	1.02
Hs 578T	AZD8055	2		sigmoid	sigmoid	Hs578T AZD8055 2	8	2.480	0.0521	0.149	0.469	0.0387	0.142	1.13	0.999	3.49e-10	NA	0.0495	0.253	0.557	0.0273	0.249	1.16	0.999	4.45e-10	NA
Hs 578T	Trametinib	2		sigmoid	sigmoid	Hs578T trametinib 2	8	2.483	0.00633	0.074	0.701	0.00558	0.0362	0.593	0.998	1.32e-08	NA	0.0058	0.214	0.361	0.00257	0.193	0.602	0.998	3.66e-09	NA
BT-20	PI103	3	72	sigmoid	sigmoid	BT20 PI-103 0 3 72	8	2.496	0.373	0.0139	0.282	0.387	-0.0286	1.52	0.994	1.99e-07	NA	0.359	0.183	0.735	0.279	0.162	1.56	0.988	1.71e-06	NA
BT-20	GDC-0980	3	72	sigmoid	sigmoid	BT20 apitolisib 0 3 72	8	2.502	0.0976	-0.115	0.437	0.107	-0.0716	1.53	0.994	2.41e-07	NA	0.0894	0.13	0.62	0.0732	0.163	1.96	0.996	6.83e-08	NA
HCC70	ZSTK474	3	72	sigmoid	sigmoid	HCC70 ZSTK474 0 3 72	8	2.502	0.455	0.176	0.223	0.345	0.155	1.35	0.991	8.07e-07	NA	0.401	0.265	0.782	0.24	0.274	1.55	0.987	1.99e-06	NA
Hs 578T	PI103	2		sigmoid	sigmoid	Hs578T PI-103 2	8	2.503	0.223	-0.0213	0.356	0.303	-0.15	0.858	0.999	7.33e-10	NA	0.206	0.167	0.661	0.152	0.121	0.921	0.999	1.9e-09	NA
Hs 578T	KIN001-244	2		sigmoid	sigmoid	Hs578T KIN001-244 2	8	2.505	Inf	0.819	0.0357	4.8	0.531	1.14	0.891	0.0013	NA	44.3	0.788	0.957	4.79	0.457	1.1	0.878	0.0018	NA
Hs 578T	Omipalisib	2		sigmoid	sigmoid	Hs578T omipalisib 2	8	2.507	0.0155	-0.52	0.766	0.239	-1.0	0.402	0.993	3.45e-07	NA	0.0114	0.028	0.355	0.0114	0.0	0.468	0.981	6.9e-06	NA
Hs 578T	AZD-6482	2		sigmoid	sigmoid	Hs578T AZD6482 2	8	2.508	6.35	0.602	0.121	74.8	-1.0	0.445	0.998	1.12e-08	NA	6.4	0.573	0.86	6.4	0.0	0.475	0.996	6.36e-08	NA
Hs 578T	Dactolisib	2		sigmoid	sigmoid	Hs578T dactolisib 2	8	2.509	0.0128	-0.0617	0.655	0.0126	0.00741	0.79	0.974	1.78e-05	NA	0.0105	0.15	0.405	0.00638	0.203	1.04	0.985	3.67e-06	NA

|<
<<
Previous
Page 12 of 18
Next
>>
>
276 to 300 of 432 records
per page:

HMS LINCS Project

Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)